↓ Skip to main content

Pertuzumab in combination with trastuzumab and chemotherapy for Chinese patients with HER2‐positive metastatic gastric or gastroesophageal junction cancer: a subpopulation analysis of the JACOB trial

Overview of attention for article published in Cancer Communications, June 2019
Altmetric Badge

Citations

dimensions_citation
23 Dimensions

Readers on

mendeley
46 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Pertuzumab in combination with trastuzumab and chemotherapy for Chinese patients with HER2‐positive metastatic gastric or gastroesophageal junction cancer: a subpopulation analysis of the JACOB trial
Published in
Cancer Communications, June 2019
DOI 10.1186/s40880-019-0384-6
Pubmed ID
Authors

Tianshu Liu, Yanru Qin, Jin Li, Ruihua Xu, Jianming Xu, Shujun Yang, Shukui Qin, Yuxian Bai, Changping Wu, Yixiang Mao, Haiyan Wu, Yilin Ge, Lin Shen

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 46 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 46 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 10 22%
Student > Master 6 13%
Student > Doctoral Student 4 9%
Student > Ph. D. Student 3 7%
Other 2 4%
Other 6 13%
Unknown 15 33%
Readers by discipline Count As %
Medicine and Dentistry 14 30%
Biochemistry, Genetics and Molecular Biology 4 9%
Pharmacology, Toxicology and Pharmaceutical Science 3 7%
Nursing and Health Professions 2 4%
Sports and Recreations 2 4%
Other 5 11%
Unknown 16 35%